These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37139247)

  • 21. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
    Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Drug Monitoring of Continuous Infusion Doripenem in a Pediatric Patient on Continuous Renal Replacement Therapy.
    Cies JJ; Moore WS; Conley SB; Shea P; Enache A; Chopra A
    J Pediatr Pharmacol Ther; 2017; 22(1):69-73. PubMed ID: 28337084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing Renal Replacement Therapy Modalities in Critically Ill Patients With Acute Kidney Injury: A Systematic Review and Network Meta-Analysis.
    Ye Z; Wang Y; Ge L; Guyatt GH; Collister D; Alhazzani W; Bagshaw SM; Belley-Cote EP; Fang F; Hou L; Kolb P; Lamontagne F; Oczkowski S; Pyne L; Rabbat C; Scaum M; Najafabadi BT; Tangamornsuksan W; Wald R; Wang Q; Walsh M; Yao L; Zeng L; Algarni AM; Couban RJ; Alexander PE; Rochwerg B
    Crit Care Explor; 2021 May; 3(5):e0399. PubMed ID: 34079944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy.
    Chen J; Li S; Wang Q; Wang C; Qiu Y; Yang L; Han R; Du Q; Chen L; Dong Y; Wang T
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy.
    Trotman RL; Williamson JC; Shoemaker DM; Salzer WL
    Clin Infect Dis; 2005 Oct; 41(8):1159-66. PubMed ID: 16163635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefepime population pharmacokinetics and dosing regimen optimization in critically ill children with different renal function.
    de Cacqueray N; Hirt D; Zheng Y; Bille E; Leger PL; Rambaud J; Toubiana J; Chosidow A; Vimont S; Callot D; Chouchana L; Béranger A; Tréluyer JM; Benaboud S; Oualha M
    Clin Microbiol Infect; 2022 Oct; 28(10):1389.e1-1389.e7. PubMed ID: 35605841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy.
    Vaara S; Pettila V; Kaukonen KM
    Acta Anaesthesiol Scand; 2012 Feb; 56(2):147-57. PubMed ID: 22092254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.
    Broeker A; Wicha SG; Dorn C; Kratzer A; Schleibinger M; Kees F; Heininger A; Kees MG; Häberle H
    Crit Care; 2018 Dec; 22(1):341. PubMed ID: 30558639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolution of pediatric continuous renal replacement therapy.
    Garzotto F; Zanella M; Ronco C
    Nephron Clin Pract; 2014; 127(1-4):172-5. PubMed ID: 25343844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A primer on continuous renal replacement therapy for critically ill patients.
    Joy MS; Matzke GR; Armstrong DK; Marx MA; Zarowitz BJ
    Ann Pharmacother; 1998 Mar; 32(3):362-75. PubMed ID: 9533067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.
    Li L; Li X; Xia Y; Chu Y; Zhong H; Li J; Liang P; Bu Y; Zhao R; Liao Y; Yang P; Lu X; Jiang S
    Front Pharmacol; 2020; 11():786. PubMed ID: 32547394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous Veno-Venous Hemodialysis Using the Cardio-Renal Pediatric Dialysis Emergency MachineTM: First Clinical Experiences.
    Vidal E; Cocchi E; Paglialonga F; Ricci Z; Garzotto F; Peruzzi L; Murer L; Ronco C
    Blood Purif; 2019; 47(1-3):149-155. PubMed ID: 30380544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lacosamide dosing in patients receiving continuous renal replacement therapy.
    Chaijamorn W; Phunpon S; Sathienluckana T; Charoensareerat T; Pattharachayakul S; Rungkitwattanakul D; Srisawat N
    J Intensive Care; 2023 Nov; 11(1):50. PubMed ID: 37946296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
    Peng Y; Cheng Z; Xie F
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0082222. PubMed ID: 36005753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefepime pharmacokinetics in critically ill children and young adults undergoing continuous kidney replacement therapy.
    Pavia K; Hambrick HR; Paice K; Tang P; Punt N; Kaplan J; Goldstein SL; Vinks AA; Mizuno T; Tang Girdwood S
    J Antimicrob Chemother; 2023 Sep; 78(9):2140-2147. PubMed ID: 37466170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
    Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.
    Ulldemolins M; Vaquer S; Llauradó-Serra M; Pontes C; Calvo G; Soy D; Martín-Loeches I
    Crit Care; 2014 Jun; 18(3):227. PubMed ID: 25042938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
    Jang SM; Infante S; Abdi Pour A
    Pharmacy (Basel); 2020 Feb; 8(1):. PubMed ID: 32046092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial Dosing Recommendations in Pediatric Continuous Renal Replacement Therapy: A Critical Appraisal of Current Evidence.
    Stitt G; Dubinsky S; Edginton A; Huang YV; Zuppa AF; Watt K; Downes K
    Front Pediatr; 2022; 10():889958. PubMed ID: 35633961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case Report: Therapeutic Drug Monitoring of Polymyxin B During Continuous Renal Replacement Therapy in Two Pediatric Patients: Do Not Underestimate Extracorporeal Clearance.
    Xu C; Liu X; Cui Y; Huang X; Wang Y; Fan Y; Wu H; Li X; Guo B; Zhang J; Zhang Y
    Front Pharmacol; 2022; 13():822981. PubMed ID: 35401193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.